HL7 Terminology (THO)
6.0.2 - Publication International flag

This page is part of the HL7 Terminology (v6.0.2: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

: TNM Staging System - JSON Representation

Active as of 2022-01-14

Raw json | Download


{
  "resourceType" : "NamingSystem",
  "id" : "TNM",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: NamingSystem TNM</b></p><a name=\"TNM\"> </a><a name=\"hcTNM\"> </a><a name=\"TNM-en-US\"> </a><h3>Summary</h3><table class=\"grid\"><tr><td>Defining URL</td><td>http://terminology.hl7.org/NamingSystem/TNM</td></tr><tr><td>Version</td><td>1.0.0</td></tr><tr><td>Name</td><td>TNM</td></tr><tr><td>Title</td><td>TNM Staging System</td></tr><tr><td>Status</td><td>active</td></tr><tr><td>Definition</td><td><div><p>The TNM Staging System was developed and is maintained by the AJCC and the Union for International Cancer Control (UICC). It is the most commonly used staging system by medical professionals around the world. The TNM classification system was developed as a tool for doctors to stage different types of cancer based on certain, standardized criteria. The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M).</p>\n<p>HTA Note: Most content of TNM (V6) is in the SNOMED international release but not content from the most recent (V9).  In Europe many countries use TNM codes, taken from the book and referenced using an OID.</p>\n</div></td></tr><tr><td>Publisher</td><td>American Joint Committee on Cancer</td></tr></table><h3>Identifiers</h3><table class=\"grid\"><tr><td><b>Type</b></td><td><b>Value</b></td><td><b>Preferred</b></td><td><b>Period</b></td><td><b>Comment</b></td></tr><tr><td>URI</td><td>https://cancerstaging.org</td><td>true</td><td>2021-11-03 --&gt; (ongoing)</td><td>This is the URL as specified by the terminology owner, and is considered authoritative.</td></tr></table></div>"
  },
  "url" : "http://terminology.hl7.org/NamingSystem/TNM",
  "version" : "1.0.0",
  "name" : "TNM",
  "title" : "TNM Staging System",
  "status" : "active",
  "kind" : "codesystem",
  "date" : "2022-01-14T00:00:00-00:00",
  "publisher" : "American Joint Committee on Cancer",
  "contact" : [
    {
      "name" : "American Joint Committee on Cancer; 633 N. Saint Clair St., Chicago, IL 60611-3211",
      "telecom" : [
        {
          "system" : "email",
          "value" : "ajcc@facs.org"
        },
        {
          "system" : "phone",
          "value" : "(312) 202-5205"
        },
        {
          "system" : "url",
          "value" : "https://cancerstaging.org/"
        }
      ]
    }
  ],
  "responsible" : "American Joint Committee on Cancer",
  "description" : "The TNM Staging System was developed and is maintained by the AJCC and the Union for International Cancer Control (UICC). It is the most commonly used staging system by medical professionals around the world. The TNM classification system was developed as a tool for doctors to stage different types of cancer based on certain, standardized criteria. The TNM Staging System is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of metastasis (M).\r\n\r\nHTA Note: Most content of TNM (V6) is in the SNOMED international release but not content from the most recent (V9).  In Europe many countries use TNM codes, taken from the book and referenced using an OID.",
  "uniqueId" : [
    {
      "type" : "uri",
      "value" : "https://cancerstaging.org",
      "preferred" : true,
      "comment" : "This is the URL as specified by the terminology owner, and is considered authoritative.",
      "period" : {
        "start" : "2021-11-03"
      }
    }
  ]
}